As of 2025-09-15, the Intrinsic Value of Globus Medical Inc (GMED) is 35.26 USD. This GMED valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 58.24 USD, the upside of Globus Medical Inc is -39.50%.
The range of the Intrinsic Value is 22.02 - 90.60 USD
Based on its market price of 58.24 USD and our intrinsic valuation, Globus Medical Inc (GMED) is overvalued by 39.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 22.02 - 90.60 | 35.26 | -39.5% |
| DCF (Growth 10y) | 39.87 - 161.51 | 63.45 | 8.9% |
| DCF (EBITDA 5y) | 37.15 - 50.61 | 39.79 | -31.7% |
| DCF (EBITDA 10y) | 54.25 - 79.92 | 60.97 | 4.7% |
| Fair Value | 13.20 - 13.20 | 13.20 | -77.33% |
| P/E | 27.32 - 107.63 | 57.32 | -1.6% |
| EV/EBITDA | 34.69 - 71.14 | 49.98 | -14.2% |
| EPV | 31.95 - 43.73 | 37.84 | -35.0% |
| DDM - Stable | 29.88 - 153.99 | 91.94 | 57.9% |
| DDM - Multi | 29.25 - 118.78 | 47.13 | -19.1% |
| Market Cap (mil) | 7,865.89 |
| Beta | 0.95 |
| Outstanding shares (mil) | 135.06 |
| Enterprise Value (mil) | 7,636.75 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.86% |
| Cost of Debt | 5.00% |
| WACC | 7.66% |